1. Episode Summary A Cure for Blindness? What the Science Really Says What does the future of vision research actually look like, and how much of the excitement surrounding new treatments translates into real options for people living with vision loss? On this episode of Navigating Life with Vision Loss, host Kim Wardlow welcomes Dr. Amy Laster, Chief Scientific Officer at the Foundation Fighting Blindness, for a conversation about the progress, possibilities, and uncertainties surrounding research into inherited retinal diseases. Dr. Laster explains why genetic testing matters for conditions such as retinitis pigmentosa, Stargardt disease, and Usher syndrome. She discusses gene therapy, cell therapy, experimental treatments, and how advances in one area of research may help scientists develop treatments for other conditions. They also explore how clinical trials work, what patients should understand before participating, and how resources such as the My Retina Tracker Registry can help individuals stay informed about research opportunities. But perhaps the most important takeaway is that progress doesn't always mean finding a cure. Sometimes it means slowing vision loss, preserving existing sight, or helping someone maintain their independence longer. Whether you're newly diagnosed, have lived with vision loss for years, or support someone navigating that journey, this conversation offers practical information, valuable resources, and a realistic look at where the science stands. 2. Credits Show: Navigating Life with Vision LossHost: Kim WardlowGuest: Dr. Amy Laster, PhDGuest Title: Chief Scientific Officer, Foundation Fighting BlindnessProducer: Jonathan PricePresented by: Aftersight3. Contact Information & Resources Foundation Fighting Blindness Website: fightingblindness.org Resources discussed include inherited retinal disease education, genetic testing, the My Retina Tracker Registry, retinal specialist directories, research opportunities, local chapters, and community support. Clinical Trials Website: ClinicalTrials.gov Search for clinical trials by condition, review eligibility requirements, and find study sponsor contact information. A listed study is not automatically an endorsement of its safety or legitimacy. Aftersight Website: aftersight.org Email: feedback@aftersight.org Phone: (720) 712-8856 4. Chapter Markers 00:11 – Understanding the Future of Vision Research02:33 – Dr. Amy Laster's Journey into Neuroscience05:50 – What to Do After a Vision Loss Diagnosis08:41 – Why Genetic Testing Matters10:58 – Why the Same Condition Affects People Differently12:49 – How Researchers Prioritize Retinal Diseases14:51 – Gene Therapy, Cell Therapy, and Emerging Treatments18:28 – New Technologies and What Progress Really Means20:01 – From Promising Research to Available Treatments23:21 – Can Treatments Work for Multiple Conditions?25:23 – Finding and Evaluating Clinical Trials28:12 – Understanding the My Retina Tracker Registry32:00 – Balancing Hope with the Reality of Research35:31 – Practical Steps for Newly Diagnosed Individuals38:27 – Resources and Support from Foundation Fighting Blindness (00:11) - Understanding the Future of Vision Research (02:57) - Dr. Amy Laster's Journey into Neuroscience (06:14) - What to Do After a Vision Loss Diagnosis (09:05) - Why Genetic Testing Matters (11:22) - Why the Same Condition Affects People Differently (13:13) - How Researchers Prioritize Retinal Diseases (15:15) - Gene Therapy, Cell Therapy, and Emerging Treatments (18:52) - New Technologies and What Progress Really Means (20:25) - From Promising Research to Available Treatments (23:45) - Can Treatments Work for Multiple Conditions? (25:47) - Finding and Evaluating Clinical Trials (28:36) - Understanding the My Retina Tracker Registry (32:24) - Balancing Hope with the Reality of Research (35:55) - Practical Steps for Newly Diagnosed Individuals (38:51) - Resources and Support from Foundation Fighting Blindness